The Studio LSD IPO is a book build issue worth ₹74.25 crores, comprising a fresh issue of 1.10 crore shares aggregating ₹59.40 crores and an offer for sale of 0.28 crore shares worth ₹14.85 crores.
The IPO opened for subscription on August 18, 2025, and closed on August 20, 2025. The allotment is expected to be finalized on August 21, 2025, while the tentative listing date is August 25, 2025, on NSE SME.
The price band is set between ₹51 – ₹54 per share, with a lot size of 2,000 shares. For retail investors, the minimum investment required is ₹2,04,000 (4,000 shares). For HNI investors, the minimum application size is 3 lots (6,000 shares) worth ₹3,24,000.
As per the latest update on August 19, 2025 (09:37 AM), the Studio LSD IPO GMP is ₹0. With the cap price of ₹54, the estimated listing price is also ₹54, indicating no listing gain (0.00%). Over the past 8 sessions, the GMP has fluctuated between ₹0 – ₹14, showing weak grey market sentiment.
Studio LSD IPO GMP – FAQs
What is Studio LSD IPO GMP Today?
The latest Studio LSD IPO GMP is ₹0 as of August 19, 2025.
What is the estimated listing price of Studio LSD IPO?
Based on today’s GMP, the estimated listing price is ₹54, equal to the upper price band.
What are the expected returns from Studio LSD IPO GMP?
Currently, expected returns are 0.00%, indicating no premium in the grey market.
What is the highest and lowest GMP of Studio LSD IPO so far?
The highest GMP recorded is ₹14, while the lowest is ₹0, showing high volatility in grey market activity.
What is Studio LSD IPO Kostak Rate Today?
As of now, the Kostak Rate for Studio LSD IPO is not available.
What is Studio LSD IPO Subject to Sauda Today?
The Subject to Sauda for Studio LSD IPO is not reported as of now.
Why is Studio LSD IPO GMP showing weak sentiment?
The low GMP indicates limited grey market interest, possibly due to the high investment requirement and cautious investor sentiment in the SME space.
Can Studio LSD IPO still give listing gains despite low GMP?
Yes, while GMP gives an early indication, final listing gains depend on subscription demand, overall market conditions, and company fundamentals.
Conclusion
Studio LSD IPO GMP currently shows no premium in the grey market, suggesting a cautious outlook from investors. While the GMP trend is downward, it’s important to note that GMP is only an indicator of early sentiment and not a guaranteed listing outcome. Investors should focus on the company’s fundamentals, SME market conditions, and long-term growth potential before making a decision. Despite weak GMP, listing surprises can still occur if subscription demand increases closer to allotment. Overall, Studio LSD IPO GMP signals a neutral market mood, and investors should evaluate carefully before applying.
Comments
0 comment